These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12109849)
1. Targeted therapeutics and implications for pathologists. Geyer SJ; Johnson PC Am J Clin Pathol; 2002 Jul; 118(1):144; author reply 144. PubMed ID: 12109849 [No Abstract] [Full Text] [Related]
2. The advent of targeted therapeutics and implications for pathologists. Hess JL Am J Clin Pathol; 2002 Mar; 117(3):355-7. PubMed ID: 11888074 [No Abstract] [Full Text] [Related]
3. Image management in pathology. Weinberg DS; Doolittle M Am J Clin Pathol; 1996 Apr; 105(4 Suppl 1):S54-9. PubMed ID: 8607463 [TBL] [Abstract][Full Text] [Related]
4. Cells carry the clue for targeted treatment: a new horizon for cytopathology. Schmitt FC Cytopathology; 2007 Oct; 18(5):275-7. PubMed ID: 17883688 [No Abstract] [Full Text] [Related]
5. [Impact of the pathology in modern medicine]. Brousset P; Delsol G Med Sci (Paris); 2011; 27(6-7):651-5. PubMed ID: 21718650 [TBL] [Abstract][Full Text] [Related]
6. Molecular imaging as a tool for personalized and targeted anticancer therapy. McLarty K; Reilly RM Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871 [No Abstract] [Full Text] [Related]
7. [Automation, informatics, telematics: what is their role?]. Clemente C; Rao S; Ferrari AM; Clemente A Pathologica; 2001 Oct; 93(5):588-90. PubMed ID: 11725364 [No Abstract] [Full Text] [Related]
8. Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and development. Hermiston TW; Kirn DH Mol Ther; 2005 Apr; 11(4):496-507. PubMed ID: 15771953 [TBL] [Abstract][Full Text] [Related]
9. A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation. Clairambault J IEEE Eng Med Biol Mag; 2008; 27(1):20-4. PubMed ID: 18270046 [No Abstract] [Full Text] [Related]
10. Digital methods in pathology - the future is already here. Wielenga VT; Vainer B APMIS; 2012 Apr; 120(4):255. PubMed ID: 22429208 [No Abstract] [Full Text] [Related]
14. Advances in molecular targets and cancer therapeutics. Westwell AD Drug Discov Today; 2004 Mar; 9(5):207-9. PubMed ID: 14980538 [No Abstract] [Full Text] [Related]
15. Cancer robustness: tumour tactics. Kitano H Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483 [No Abstract] [Full Text] [Related]
16. [Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists]. Jacquemier J; Ginestier C; Charafe-Jauffret E; Bertucci F; Bege T; Geneix J; Birnbaum D Ann Pathol; 2003 Dec; 23(6):623-32. PubMed ID: 15094604 [TBL] [Abstract][Full Text] [Related]
17. The convergence of cancer prevention and therapy in early-phase clinical drug development. Abbruzzese JL; Lippman SM Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755 [TBL] [Abstract][Full Text] [Related]